Finance

Beta
Lists
WHWK:NASDAQ
Whitehawk Therapeutics Inc
$4.41
+6.01%
(+0.25) 1D
$4.33
-1.81% (-0.080)
After hours
Closed: Jun 29, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for WHWK...
Open
$4.16
High
$4.44
Low
$4.02
Mkt. cap
237.18M
Avg. vol.
448.98K
Volume
356.40K
52-wk high
$5.50
52-wk low
$1.57
EPS
-$3.59
Beta
0.77
Shares outstanding
53.78M
No. of employees
29
Open
$4.16
High
$4.44
Low
$4.02
Mkt. cap
237.18M
Avg. vol.
448.98K
Volume
356.40K
52-wk high
$5.50
52-wk low
$1.57
EPS
-$3.59
Beta
0.77
Shares outstanding
53.78M
No. of employees
29
News stories
From sources across the web
About Whitehawk Therapeutics Inc
CEO-
Employees29
Founded2007
Headquarters-
SectorBiotechnology
Websiteir.whitehawktx.com
Analyst ratings
Based on 6 analysts giving stock ratings to WHWK in the past 3 months
Buy
Buy
4
Hold
2
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for WHWK in the last 3 months.
Highest
Current $4.41
$10.00 (+126.76%)
Average
$8.00 (+81.41%)
Lowest
$7.00 (+58.73%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yuan Zhi
B. Riley Securities
Buy
Initiated
$10.00
+126.8%
06/25/2026
Boris Peaker
JonesTrading
Buy
Maintained
$7.00
+58.7%
05/22/2026
Jeff Jones
Oppenheimer
Buy
Reiterated
$7.00
+58.7%
05/08/2026
Tara Bancroft
TD Cowen
Hold
Maintained
-
-
05/07/2026
Robert Burns
H.C. Wainwright
Hold
Reiterated
-
-
04/21/2026
Reni Benjamin
Citizens JMP
Buy
Initiated
$8.00
+81.4%
04/16/2026
Soumit Roy
JonesTrading
Buy
Maintained
$7.00
+58.7%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
48.81M
14.34M
19.02M
17.23M
Cost of revenue
48.81M
14.34M
19.02M
17.23M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.94M
5.20M
5.87M
6.29M
Operating expense
5.94M
5.20M
5.87M
6.29M
Total operating expenses
54.75M
19.55M
24.89M
23.52M
Operating income
-54.75M
-19.55M
-24.89M
-23.52M
Other non operating income
158.00K
127.00K
17.00K
-
EBT including unusual items
-52.62M
-17.75M
-23.25M
-22.19M
EBT excluding unusual items
-52.62M
-17.57M
-23.25M
-22.19M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-52.62M
-17.75M
-23.25M
-22.19M
Net profit margin
-
-
-
-
Earnings per share
-0.76
-0.25
-0.34
-0.32
Interest and investment income
1.98M
1.85M
1.61M
1.33M
Interest expense
-
-
-
-
Net interest expenses
1.98M
1.85M
1.61M
1.33M
Depreciation and amortization charges
-
-
-
-
EBITDA
-54.73M
-19.54M
-24.89M
-23.52M
Gain or loss from assets sale
-
177.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer